Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders

被引:20
|
作者
Tillema, J. M. [1 ]
Leach, J. [2 ]
Pirko, I. [1 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[2] Cincinnati Childrens Hosp, Dept Radiol, Med Ctr, Cincinnati, OH USA
关键词
Pediatric; multiple sclerosis; acute disseminated encephalomyelitis; MRI; DIFFUSION-TENSOR MR; PROGNOSTIC-FACTORS; RADIAL DIFFUSIVITY; IMAGING DETECTS; DAMAGE; BRAIN; MS; ABNORMALITIES; CHILDHOOD; CHILDREN;
D O I
10.1177/1352458512447527
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To analyze diffusion tensor imaging (DTI) derived metrics between patients with childhood onset multiple sclerosis (MS), monophasic demyelinating illnesses, and healthy controls. Background: Monophasic demyelinating illnesses can be indistinguishable clinically and radiologically, utilizing standard MRI studies. DTI studies in adults implicate the involvement of normal-appearing white matter (NAWM) in MS. Methods: Subjects with DTI studies (15 directions, 1.5 Tesla (GE), 3x3x3 mm, interpolated to 1.5x1.5x3 mm) were retrospectively identified. We studied three groups: childhood onset MS (n=18), monophasic illness (eight with acute disseminated encephalomyelitis (ADEM), seven with clinically isolated syndrome (CIS)) and age-matched controls. DTI had been obtained within one month of symptom onset for patients with ADEM and within a median of 20 months for the MS group. DTI measures were determined using a semi-automated method from standardized regions of interest (ROI) containing central fibers of the corpus callosum genu and internal capsule. Results: The MS group had significantly lower fractional anisotropy (FA) values compared to controls (p<0.001), with increased radial diffusivity (RD) and decreased axial diffusivity (AD). In the monophasic group FA was smaller than the controls (p=0.01) with increased RD and no difference in AD. Conclusions: This retrospective analysis provides evidence that NAWM is affected in pediatric MS and monophasic demyelinating disease, with a potentially novel pattern demonstrating reduced AD in pediatric MS. Further larger scale confirmatory studies are needed to address whether the demonstrated DTI changes could be used as a biomarker in pediatric patients presenting with an initial demyelinating event.
引用
收藏
页码:1754 / 1759
页数:6
相关论文
共 50 条
  • [41] Fatigue and depression in pediatric multiple sclerosis and monophasic variants
    Ketelslegers, I. A.
    Neuteboom, R. F.
    Boon, M.
    Castman-Berrevoets, C. E.
    Hintzen, R. Q.
    MULTIPLE SCLEROSIS, 2008, 14 : S143 - S143
  • [42] Bacterial load of non-lesional skin on pediatric atopic dermatitis and food allergy
    Dahal, Arya
    Chang, Wan Chi
    Grashel, Brittany
    Morgan, David
    Biagini, Jocelyn
    Hershey, Gurjit Khurana
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB81 - AB81
  • [43] Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations
    Ghezzi, Angelo
    Banwell, Brenda
    Bar-Or, Amit
    Chitnis, Tanuja
    Dale, Russell C.
    Gorman, Mark
    Kornek, Barbara
    Krupp, Lauren
    Krysko, Kristen M.
    Nosadini, Margherita
    Rostasy, Kevin
    Salzer, Jonatan
    Schreiner, Teri
    Tenembaum, Silvia
    Waubant, Emmanuelle
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (12) : 1814 - 1822
  • [44] NODDI disclose early changes in the normal appearing white matter in pediatric onset multiple sclerosis.
    Margoni, M.
    Villani, U.
    Rubin, M.
    Franciotta, S.
    Nosadini, M.
    Sartori, S.
    Anglani, M.
    Causin, F.
    Perini, P.
    Rinaldi, F.
    Bertoldo, A.
    Gallo, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 229 - 229
  • [45] Reply: Non-multiple sclerosis recurrent demyelinating disorders: an ongoing debate
    Lassmann, Hans
    BRAIN, 2010, 133 : E151 - E151
  • [46] Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis
    Horellou, Philippe
    Wang, Min
    Keo, Vixra
    Chretien, Pascale
    Serguera, Che
    Waters, Patrick
    Deiva, Kumaran
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 289 : 1 - 7
  • [47] Cellular signature changes in non-lesional tissue from multiple sclerosis donors revealed by single-nucleus RNA-seq and spatial transcriptomics
    Lam, M.
    Fujita, M.
    Lee, D.
    Kosater, I.
    Taga, M.
    Zhang, Y.
    Khairallah, A.
    Bush, E.
    Sims, P.
    Nag, S.
    Bennett, D. A.
    De Jager, P. L.
    Menon, V.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 223 - 224
  • [48] White Matter Tract Based DTI Analysis in Pediatric Multiple Sclerosis
    Vishwas, Mellekate S.
    Chitnis, Tanuja
    Pienaar, Rudolph
    Healy, Brian C.
    Grant, Ellen P.
    NEUROLOGY, 2009, 72 (11) : A371 - A371
  • [49] Amygdala subnuclear volumes in temporal lobe epilepsy with hippocampal sclerosis and in non-lesional patients
    Ballerini, Alice
    Tondelli, Manuela
    Talami, Francesca
    Molinari, Maria Angela
    Micalizzi, Elisa
    Giovannini, Giada
    Turchi, Giulia
    Malagoli, Marcella
    Genovese, Maurilio
    Meletti, Stefano
    Vaudano, Anna Elisabetta
    BRAIN COMMUNICATIONS, 2022, 4 (05)
  • [50] Very-long T2-weighted imaging of the non-lesional brain tissue in multiple sclerosis patients
    Bontempi, Pietro
    Marangoni, Sabrina
    Cazzoletti, Lucia
    Bajrami, Albulena
    Giometto, Bruno
    Farace, Paolo
    Rozzanigo, Umberto
    NMR IN BIOMEDICINE, 2024, 37 (12)